% Expired Patents = 20.0

EPO Patents = 1

Forward Citations = 8

Loading Chart...

14 inventors (with patents filed for the assignee):

Satoshi Yomoda (5 out of 5 patents)

Toshiki Okubo (4 out of 4 patents)

Hiroyasu Esumi (4 out of 4 patents)

4. Takanori Kawashima (3 out of 3 patents)

5. Shigetoshi Kadota (3 out of 6 patents)

6. Chika Miyoshi (3 out of 3 patents)

7. Masafumi Ikeda (2 out of 3 patents)

8. Shigeki Chiba (2 out of 2 patents)

9. Takafumi Fuse (2 out of 2 patents)

10. Katsuya Tsuchihara (1 out of 1 patent)

11. Yasuhiro Tezuka (1 out of 1 patent)

12. Kenta Murata (1 out of 1 patent)

13. Keiichi Yamamoto (1 out of 1 patent)

14. Ryuji Takahashi (1 out of 1 patent)

15. R Kanebo Ltd Takahashi (0 patent)

5 patents: Sort by Forward Citations

1. 9907852 - Anticancer agent and side-effect-alleviating agent (2018-03-06),

2. 9700572 - Anti-cancer agent (2017-07-11),

3. 9586921 - Burdock fruit extract containing arctigenin at high content and process for producing same (2017-03-07),

4. 9072718 - Burdock fruit extract containing arctigenin and method for producing same (2015-07-07),

5. 7550436 - Compositions containing peptide and electrolyte excretion promoter and foods containing the same (2009-06-23),

Company Overview

Kracie Pharma, Ltd. is a leading pharmaceutical company dedicated to improving global health through innovative drugs and healthcare solutions. With a strong focus on research and development, Kracie Pharma strives to deliver high-quality products that meet the needs of healthcare professionals and patients worldwide. Through a commitment to excellence and a passion for innovation, Kracie Pharma is making a positive impact on the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#2,721 in Tokyo

#6,652 in Japan

Tokyo, Japan

Kracie Pharma, Ltd.

Forward Citations = 8

14 inventors:

Satoshi Yomoda (5 out of 5 patents)

Toshiki Okubo (4 out of 4 patents)

Hiroyasu Esumi (4 out of 4 patents)

4. Takanori Kawashima (3 out of 3 patents)

5. Shigetoshi Kadota (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kracie Pharma, Ltd.. Retrieved from https://idiyas.com/company/kracie-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]